Original Research
Published on 16 Mar 2023
Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1156455
- 6,556 views
- 12 citations


